Business

Roche Collaborates with OASES to Drive Primary Healthcare Transformation and Innovation, Strengthening Hong Kong's Position as a Global Healthcare Hub

Roche announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelerate healthcare innovation and strengthen Hong Kong's role as a leading hub for life sciences and medical technology in the Asia Pacific region.

articleRoche Holding LtdOctober 10, 20254/company/roche-holding-ltd/news/roche-collaborates-with-oases-to-drive-primary-healthcare-transformation-and-innovation-strengthening-hong-kongs-position-as-a-global-healthcare-hub
Roche Collaborates with OASES to Drive Primary Healthcare Transformation and Innovation, Strengthening Hong Kong's Position as a Global Healthcare Hub

About this update from Roche Holding Ltd

[{"type":"text","content":"HONG KONG, Oct. 10, 2025 /PRNewswire/ -- Roche announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelerate healthcare innovation and strengthen Hong Kong's role as a leading hub for life sciences and medical technology in the Asia Pacific region.","length":303,"tagName":"p"},{"type":"text","content":"As part of this announcement, Roche will strengthen its presence in Hong Kong over the next five years. The collaboration is a joint effort between its Pharmaceutical and Diagnostics divisions, with each providing distinct perspectives and advantages. This commitment reflects Roche's confidence in Hong Kong's long-term potential as a center for medical innovation.","length":374,"tagName":"p"},{"type":"text","content":"Hong Kong has a supportive government ecosystem for healthcare innovation — its strategic initiatives to advance primary care and collaborative regional frameworks provide an ideal environment for Roche to deliver tailored solutions. Whether it is AI‑enabled diagnostics or advanced therapies, Roche is committed and eager to work alongside local partners to improve patient outcomes.","length":384,"tagName":"p"},{"type":"text","content":"Looking ahead, Roche will continue strengthening its commitment to Hong Kong's scientific landscape and supporting the Primary Healthcare Blueprint through the following initiatives:","length":186,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Strengthening Diabetes and Chronic Disease Management – Advancing Point-of-Care Testing (POCT) to promote early intervention and better management of chronic diseases and introducing the first Continuous Glucose Monitoring (CGM) technology enhanced with AI algorithms for improved diabetes management.","length":301,"tagName":"p"}]},{"val":[{"type":"text","content":"Driving Innovation in Ophthalmology – Developing innovative treatments that reduce the frequency of injections for patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) and broadening AI Optical Coherence Tomography (AI-OCT) screenings for the public.","length":296,"tagName":"p"}]},{"val":[{"type":"text","content":"Pandemic Influenza Preparedness – Working with the government to enhance preparedness and strengthen economic resilience.","length":121,"t...

More updates from Roche Holding Ltd

RocheHONG KONGOASEShealthcare innovationmedical technologystrategic initiativesPrimary Healthcare Blueprint